Home > NewsRelease > Printing Human Organs
Text
Printing Human Organs
From:
Joyce L. Gioia, CMC, CSP --  The Herman Group Joyce L. Gioia, CMC, CSP -- The Herman Group
Austin, TX
Wednesday, May 9, 2018

 

The Herman Trend Alert

May 9, 2018

Printing Human Organs

Recently, we have taken a step closer to commercializing the 3D printing of human replacement organs. The biotech company Organovo, based in San Diego, now believes that its bioprinted tissue can be used to test drug safety. The United States Food and Drug Administration (FDA) thinks so, too.

Turning donor cells into pieces of organs

This new process turns cells from donor organs into a printable bio-ink. Organovo is growing small organoids and using them to treat chronic conditions.

How to print 3D tissue

First, researchers must take and culture human liver cells in the right medium, so that they multiply. Second, they load the cultured cells into a specialized bioprinter. The bioprinter layers the cells onto a supportive water-based gel lattice. Finally, the researchers must wait for the cells to grow into developed tissue ready for transplanting.

Approval to treat disease with organoids

It could also be used more directly to treat patients. In late 2017, the FDA granted Organovo an orphan drug designation to use its 3D printed liver tissue. Orphan drug designation is a special status given to drugs used to treat rare diseases and conditions. The specific disease approved for treatment was alpha-1 antitrypsin deficiency, a rare inherited condition that includes chronic cough, emphysema and even COPD (Chronic Obstructive Pulmonary Disease).

Creating a bridge to transplant

One of the scientists funded by the MRC Centre for Regenerative Medicine at the University of Edinburgh is Professor David Hay. His team has not only been successful in developing liver cells, but they have found a way to keep the cells alive for a year. His immediate objective is to create an organoid as a "bridge to transplant". Long-term, Dr. Hay hopes to offer a liver implant that will provide longer liver support.

Avoiding rejection

Using stem-cell-derived tissue helps the body to accept the new organoid, because it is not recognized as "foreign" by the body. This method also means that patients implanted with this tissue will not need the standard immunosuppression treatments usually necessary for patients who receive organ transplants.

What is coming next?

Successful bioprinting of liver organoids bodes well for 3D printing of other organs, including hearts and kidneys. Regenerative medicine holds the promise of alleviating the shortage of organs for transplant.

Special thanks to Hasan Chowdhury writing in The Financial Times. To read the whole article, visithttps://www.ft.com/content/67e3ab88-f56f-11e7-a4c9-bbdefa4f210b.


© Copyright 1998-2018 by The Herman Group, Inc. -- reproduction for publication is encouraged, with the following attribution: From "The Herman Trend Alert," by Joyce Gioia, Strategic Business Futurist. 336-210-3548 or http://www.hermangroup.com. To sign up, visit http://www.HermanTrendAlert.com. The Herman Trend Alert is a trademark of The Herman Group, Inc."

 

The Herman Group is a firm of Strategic Business Futurists concentrating on workforce and workplace issues. We forecast the future and advise clients regarding relevant trends and how those trends may affect their lives. Applying our expertise as Certified Management Consultants, we advise corporate leaders regarding employee retention and organizational development to help them build workforce stability. We help organizations become Employers of Choice®. We also work with Employer of Choice, Inc. to formally recognize employers that meet the stringent standards dictated by the labor marketplace. As authors of management books and as active professional speakers, we inform and inspire people to make a positive difference in the world of work.

You did really get the ball rolling with our retention presentation, overall we have seen a move in the right direction with our turnover. 

In practice since 1980, we have served a wide variety of clients throughout the United States and in other countries. Our global affiliates assist us in sharing our expertise and advice with clients internationally. Our team of professional consultants and trainers is supported by an administrative staff that gets things done. We also have consultants certified to deliver our programs in your local area.

Delivering to both small and large groups across 100 industries, The Herman Group has provided over 2,500 educational and informative keynote speeches and training seminars worldwide.

Based in Greensboro, North Carolina, we travel extensively to meet the needs of our clients. We can always be reached through the support team in our office at (800) 227-3566. Overseas callers may reach us through 336-210-3547.

Should you have any questions after touring our website, please call or e-mail us at info@hermangroup.com.

Get started now on improving the stability and performance of your workforce and increase your chances for success in the future.

                             

News Media Interview Contact
Name: Joyce L. Gioia, CMC, CSP
Title: Certified Speaking Professional and Management Consultant
Group: The Herman Group
Dateline: Austin, TX United States
Direct Phone: 336-210-3548
Main Phone: 800-227-3566
Cell Phone: 336-210-3548
Jump To Joyce L. Gioia, CMC, CSP --  The Herman Group Jump To Joyce L. Gioia, CMC, CSP -- The Herman Group
Contact Click to Contact
Other experts on these topics